Pharmacophore modeling and docking studies on some nonpeptide-based caspase-3 inhibitors

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Sharma, Simant ^a   Basu, Arijit ^b   Agrawal, R K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; HYDROGEN; PROTON; PYRROLO[3,4 C]QUINOLINE 1,3 DIONE DERIVATIVE; UNCLASSIFIED DRUG; CASPASE INHIBITOR; QUINOLINE; QUINOLINE DERIVATIVE;

ARTICLE; ENZYME INHIBITION; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR RECOGNITION; PHARMACOPHORE; PROTON TRANSPORT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; HUMAN; METABOLISM; SYNTHESIS;

CASPASE 3; CASPASE INHIBITORS; DRUG DESIGN; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOLINES;

EID: 84884856491     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/306081     Document Type: Article

References (33)

1. Wellington C. L., Hayden M. R., Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clinical Genetics 2000 57 1 1 10 2-s2.0-0033953015 10.1034/j.1399-0004.2000.570101.x (Pubitemid 30105555)
2. Haunstetter A., Izumo S., Apoptosis: basic mechanisms and implications for cardiovascular disease. Circulation Research 1998 82 11 1111 1129 2-s2.0-0032526374 (Pubitemid 28311120)
3. Hoglen N. C., Chen L., Fisher C. D., Hirakawa B. P., Groessl T., Contreras P. C., Characterization of IDN-6556 (3-[2-(2-tert-butyl- phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5, 6-tetrafluoro-phenoxy) -pentanoic acid): a liver-targeted caspase inhibitor. Journal of Pharmacology and Experimental Therapeutics 2004 309 2 634 640 2-s2.0-2142810153 10.1124/jpet.103.062034 (Pubitemid 38542617)
4. Jacobson M. D., Anti-apoptosis therapy: a way of treating neural degeneration? Current Biology 1998 8 12 R418 R421 2-s2.0-0032482380 (Pubitemid 28286269)
5. Mohr A., Zwacka R. M., In situ trapping of initiator caspases reveals intermediate surprises. Cell Biology International 2007 31 5 526 530 2-s2.0-34247133101 10.1016/j.cellbi.2006.11.016 (Pubitemid 46602989)
6. Marques C. A., Keil U., Bonert A., Steiner B., Haass C., Müller W. E., Eckert A., Neurotoxic mechanisms caused by the alzheimer's disease-linked Swedish amyloid precursor protein. Mutation oxidative stress, caspases, and the JNK pathway. The Journal of Biological Chemistry 2003 278 30 28294 28302 2-s2.0-0042847291 10.1074/jbc.M212265200 (Pubitemid 36900031)
7. Chapman J. G., Magee W. P., Stukenbrok H. A., Beckius G. E., Milici A. J., Tracey W. R., A Novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. European Journal of Pharmacology 2002 456 1-3 59 68 2-s2.0-0037027922 10.1016/S0014-2999(02)02484-6 (Pubitemid 35351737)
8. Scott C. W., Sobotka-briner C., Wilkins D. E., Jacobs R. T., Folmer J. J., Frazee W. J., Bhat R. V., Ghanekar S. V., Aharony D., Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis. Journal of Pharmacology and Experimental Therapeutics 2003 304 1 433 440 2-s2.0-0037214559 10.1124/jpet.102.039651 (Pubitemid 36008957)
9. Anselmo D. M., Amersi F. F., Shen X., Gao F., Katori M., Lassman C., Ke B., Coito A. J., Ma J., Brinkmann V., Busuttil R. W., Kupiec-Weglinski J. W., Farmer D. G., FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. The American Journal of Transplantation 2002 2 9 843 849 2-s2.0-0036820441 10.1034/j.1600-6143.2002. 20906.x (Pubitemid 36306839)
10. Webber S. E., Tikhe J., Worland S. T., Fuhrman S. A., Hendrickson T. F., Matthews D. A., Love R. A., Patick A. K., Meador J. W., Ferre R. A., Brown E. L., Delisle D. M., Ford C. E., Binford S. L., Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. Journal of Medicinal Chemistry 1996 39 26 5072 5082 2-s2.0-12644306888 10.1021/jm960603e (Pubitemid 27008954)
11. Webber S. E., Okano K., Little T. L., Reich S. H., Xin Y., Fuhrman S. A., Matthews D. A., Love R. A., Hendrickson T. F., Patick A. K., Meador J. W. III, Ferre R. A., Brown E. L., Ford C. E., Binford S. L., Worland S. T., Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. Journal of Medicinal Chemistry 1998 41 15 2786 2805 2-s2.0-14444269890 10.1021/jm980071x (Pubitemid 28350345)
12. Wang Q. M., Johnson R. B., Jungheim L. N., Cohen J. D., Villarreal E. C., Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicrobial Agents and Chemotherapy 1998 42 4 916 920 2-s2.0-0031968180 (Pubitemid 28216379)
13. Lakshmi P. J., Kumar B. V. S. S., Nayana R. S., Mohan M. S., Bolligarla R., Das S. K., Bhanu M. U., Kondapi A. K., Ravikumar M., Design, synthesis, and discovery of novel non-peptide inhibitor of caspase-3 using ligand based and structure based virtual screening approach. Bioorganic and Medicinal Chemistry 2009 17 16 6040 6047 2-s2.0-68249156804 10.1016/j.bmc.2009.06.069
14. Garcia-Calvo M., Peterson E. P., Leiting B., Ruel R., Nicholson D. W., Thornberry N. A., Inhibition of human caspases by peptide-based and macromolecular inhibitors. The Journal of Biological Chemistry 1998 273 49 32608 32613 2-s2.0-0032484008 10.1074/jbc.273.49.32608 (Pubitemid 28557641)
15. Karanewsky D. S., Bai X., Linton S. D., Krebs J. F., Wu J., Pham B., Tomaselli K. J., Conformationally constrained inhibitors of caspase-1 (interleukin-1 β converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, APOPAIN). Bioorganic and Medicinal Chemistry Letters 1998 8 19 2757 2762 2-s2.0-0032491247 10.1016/S0960-894X(98)00498-3 (Pubitemid 28496666)
16. Grimm E. L., Roy B., Aspiotis R., Bayly C. I., Nicholson D. W., Rasper D. M., Renaud J., Roy S., Tam J., Tawa P., Vaillancourt J. P., Xanthoudakis S., Zamboni R. J., Solid phase synthesis of selective caspase-3 peptide inhibitors. Bioorganic and Medicinal Chemistry 2004 12 5 845 851 2-s2.0-10744225187 10.1016/j.bmc.2004.01.007 (Pubitemid 38251275)
17. Choong I. C., Lew W., Lee D., Pham P., Burdett M. T., Lam J. W., Wiesmann C., Luong T. N., Fahr B., DeLano W. L., McDowell R. S., Allen D. A., Erlanson D. A., Gordon E. M., O'Brien T., Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design. Journal of Medicinal Chemistry 2002 45 23 5005 5022 2-s2.0-0037038325 10.1021/jm020230j (Pubitemid 35278696)
18. Becker J. W., Rotonda J., Soisson S. M., Aspiotis R., Bayly C., Francoeur S., Gallant M., García-Calvo M., Giroux A., Grimm E., Han Y., McKay D., Nicholson D. W., Peterson E., Renaud J., Roy S., Thornberry N., Zamboni R., Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis. Journal of Medicinal Chemistry 2004 47 10 2466 2474 2-s2.0-2342531089 10.1021/jm0305523 (Pubitemid 38580085)
19. Karki R. G., Kulkarni V. M., A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors. European Journal of Medicinal Chemistry 2001 36 2 147 163 2-s2.0-0035246393 10.1016/S0223-5234(00)01202-2 (Pubitemid 32304517)
20. Singh N., Nolan T. L., McCurdy C. R., Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists. Journal of Molecular Graphics and Modelling 2008 27 2 131 139 2-s2.0-52049125021 10.1016/j.jmgm.2008.03.007
21. Burnett J. C., Wang C., Nuss J. E., Nguyen T. L., Hermone A. R., Schmidt J. J., Gussio R., Wipf P., Bavari S., Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease. Bioorganic and Medicinal Chemistry Letters 2009 19 19 5811 5813 2-s2.0-69949102167 10.1016/j.bmcl.2009. 01.111
22. Shah U. A., Deokar H. S., Kadam S. S., Kulkarni V. M., Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors. Molecular Diversity 2010 14 3 559 568 2-s2.0-78650177876 10.1007/s11030-009-9183-3
23. van Drie J. H., Strategies for the determination of pharmacophoric 3D database queries. Journal of Computer-Aided Molecular Design 1997 11 1 39 52 2-s2.0-0030639430 (Pubitemid 127505889)
24. Clement O. A., Mehl A. T., Guner O. F., HipHop: pharmacophores based on multiple common-feature alignments. Pharmacophore Perception, Development and Use in Drug Design 2000 La Jolla, Calif, USA International University Line 69 84
25. Maestro, Maestro, version 8.5. Schrödinger, LLC, New York, NY, USA
26. Phase, version 3.0. Schrödinger, LLC, New York, NY, USA
27. Kravchenko D. V., Kysil V. V., Ilyn A. P., Tkachenko S. E., Maliarchouk S., Okun I. M., Ivachtchenko A. V., 1,3-dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3, 4-c]quinolines as potent caspase-3 inhibitors. Bioorganic and Medicinal Chemistry Letters 2005 15 7 1841 1845 2-s2.0-15044358314 10.1016/j.bmcl.2005.02. 027 (Pubitemid 40380744)
28. Kravchenko D. V., Kysil V. M., Tkachenko S. E., Maliarchouk S., Okun I. M., Ivachtchenko A. V., Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4- sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones. European Journal of Medicinal Chemistry 2005 40 12 1377 1383 2-s2.0-27744531923 10.1016/j.ejmech.2005.07.011 (Pubitemid 41618281)
29. Golbraikh A., Shen M., Xiao Z., Xiao Y., Lee K. H., Tropsha A., Rational selection of training and test sets for the development of validated QSAR models. Journal of Computer-Aided Molecular Design 2003 17 2-4 241 253 2-s2.0-0042355453 10.1023/A:1025386326946 (Pubitemid 37062785)
30. Ajmani S., Kulkarni S. A., A dual-response partial least squares regression QSAR model and its application in design of dual activators of PPAR α and PPAR γ QSAR and Combinatorial Science 2008 27 11-12 1291 1304 2-s2.0-58149127485 10.1002/qsar.200860023
31. Glide, version 5.0. Schrödinger, LLC, New York, USA
32. Sharma S., Ravichandran V., Jain P. K., Mourya V. K., Agrawal R. K., Prediction of caspase-3 inhibitory activity of 1,3-dioxo-4-methyl-2,3-dihydro- 1h-pyrrolo[3,4-c] quinolines: QSAR study. Journal of Enzyme Inhibition and Medicinal Chemistry 2008 23 3 424 431 2-s2.0-46649101520 10.1080/ 14756360701652476 (Pubitemid 351935066)
33. Bissantz C., Kuhn B., Stahl M., A medicinal chemist's guide to molecular interactions. Journal of Medicinal Chemistry 2010 53 14 5061 5084 2-s2.0-77953631827 10.1021/jm100112j